International Clinical Trial: A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519395) titled 'A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)' on April 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: GlaxoSmithKline

Condition: Irritable Bowel Syndrome

Intervention: Drug: Placebo

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 6, 2026

Target Sample Size: 420

To ...